AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TRASTUZUMAB EMTANSINE
8 registrations across 4 African markets— 8 active
Markets with TRASTUZUMAB EMTANSINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Kadcyla Solution for injection in vial | 🇿🇲Zambia | Roche Products | active | Mar 2031 |
| kadcyla Solution For Infusion | 🇿🇲Zambia | Roche Products | active | Jan 2031 |
| Kadcyla Powder for Concentrate for Solution for Infusion 100 mg** Powder for concentrate for solution for infusion | 🇳🇬Nigeria | Roche Products Limited | active | May 2028 |
| Kadcyla Powder for Concentrate for Solution for Infusion 160 mg** Powder for concentrate for solution for infusion | 🇳🇬Nigeria | Roche Products Limited | active | May 2028 |
| Kadcyla 100 mg Powder For Concentrate For Solution For Infus | 🇰🇪Kenya | F. Hoffman-La Roche Ltd | active | Apr 2028 |
| Kadcyla 160 mg Powder For Concentrate For Solution For Infus | 🇰🇪Kenya | F. Hoffmann-La Roche Ltd. | active | Apr 2028 |
| KADCYLA® 100MG PPS PERF IV BTE(1FL) ROCHE PRODUCTS Poudre pour solution à diluer | 🇲🇬Madagascar | ROCHE PRODUCTS (Pty) LTD | active | — |
| KADCYLA® 100MG PPS PERF IV BTE(1FL) ROCHE PRODUCTS Poudre pour solution à diluer | 🇲🇬Madagascar | ROCHE PRODUCTS (Pty) LTD | active | — |
TRASTUZUMAB EMTANSINE in Africa — Regulatory Overview
TRASTUZUMAB EMTANSINE is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Madagascar, Nigeria, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 8 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.